Upgrade to SI Premium - Free Trial

Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.05

August 8, 2017 4:35 PM

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.05), versus $0.00 reported last year. Revenue for the quarter came in at $8.67 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

Categories

Earnings Guidance